CBUS Nasdaq Agricultural Chemicals Financials FY2016βFY2025
Cibus, Inc. had $3.6M of revenue in fiscal 2025, down 14.6% on the year before. Over five years, revenue changed β31.3% a year on average.
Last close Β· Oct 23, 2026
$1.41
0.7%Hi! I read Cibus, Inc.βs latest annual report (fiscal 2025). Here is what stands out:
Good So-so Weak
Are sales growing?
β14.6%
No. Sales fell 14.6% last year.
Does it make a profit?
β3,492.3%
No. It lost money last year.
Does profit turn into cash?
β1,406.1%
No. It spent more cash than it brought in.
How healthy are the accounts?
3 / 8
Weak. It passes 3 of 8 health tests.
How is the share priced?
β
No P/E: it made no profit over the last four quarters.
Rules of thumb on reported numbers. A starting point, not a recommendation.
Is it selling more, and how much does it keep?
In plain words: Every quarter, companies publish how much they sold and earned. These are the days Cibus, Inc. did it, and the next one. Share prices often move a lot on those days.
Next results
November 12, 2026
Thursday Β· in 17 days
| Date | Results for | Time | Source |
|---|---|---|---|
| Aug 13, 2026 | Q2 '26 | After the market closes | 8-K β |
| May 14, 2026 | Q1 '26 | After the market closes | 8-K β |
| Mar 17, 2026 | Q4 '25 | After the market closes | 8-K β |
| Nov 13, 2025 | Q3 '25 | After the market closes | 8-K β |
| Aug 14, 2025 | Q2 '25 | After the market closes | 8-K β |
| May 8, 2025 | Q1 '25 | After the market closes | 8-K β |
| Mar 20, 2025 | Q4 '24 | After the market closes | 8-K β |
| Nov 7, 2024 | Q3 '24 | After the market closes | 8-K β |
From SEC filings: the results press release (8-K) or, without one, the quarterly or annual report.
KIRA Β· Cibus, Inc. had $3.6M of revenue in fiscal 2025, down 14.6% on the year before. Over five years, revenue changed β31.3% a year on average. Its operating margin was β2,680.1%, up 3,382.7Β pts: of every 100 in sales, about β2,680 is left after running the business.
In plain words: Revenue is all the money customers paid. The margins show how many cents of each dollar of sales are left over at each step: after making the product (gross), after running the business (operating) and after everything, tax included (net).
Revenue
Revenue
Margins, % of revenue
Margins, % of revenue
KIRA Β· Cibus, Inc. lost $127M in fiscal 2025.
Loss periods are shown in red.
In plain words: Net income is the profit left after every cost and tax. Earnings per share (EPS) splits that profit across every share, so it shows what one share earned.
Net income
Net income
Diluted EPS
Diluted EPS
How much cash comes in, and where does it go?
KIRA Β· Free cash flow was β$51.2M in fiscal 2025, β1,406.1% of revenue.
Cash from operations minus capital spending.
In plain words: Profit on paper is not the same as cash in the bank. Free cash flow is the cash left after paying to run and maintain the business: the money it can hand back to shareholders, save or invest.
Free cash flow
Free cash flow
Cash from operations vs capital spending
Cash from operations vs capital spending
In plain words: Companies hand cash back in two ways: dividends (cash paid to shareholders) and buybacks (buying back their own shares, so each remaining share owns a bigger slice).
Dividends and buybacks
Diluted shares outstanding (annual)
KIRA Β· No open-market insider trades in the last 12 months.
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. βPlanβ marks trades under a pre-arranged Rule 10b5-1 plan.
In plain words: Insiders are the people who run or own a big part of the company. Buying with their own money can signal confidence; selling often has personal reasons, like taxes or diversifying.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Can it carry its debts, and how well does it use its money?
KIRA Β· Cibus, Inc. has $9.4M more cash than debt.
Cash, debt and the ratios that show how comfortably Cibus, Inc. can carry it.
In plain words: What the company owns and what it owes. More cash than debt is a cushion for bad times; a lot of debt leaves less room when business slows down.
Cash vs debt (incl. leases)
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $13.8M | $3.4M | $32.7M | $14.4M | $9.9M |
| Debt incl. finance leases | $0.0M | $0.1M | $1.7M | $0.8M | $0.5M |
| Debt / equity | 0.0x | 0.0x | 0.0x | 0.0x | 0.0x |
| Interest coverage | β20.5x | β298.3x | β | β | β |
| Current ratio | 3.1x | 2.5x | 1.7x | 0.9x | 0.7x |
| Quick ratio | 3.1x | 2.5x | 1.7x | 0.9x | 0.7x |
| Total assets | $37.2M | $22.4M | $544M | $350M | $305M |
| Total liabilities | $23.1M | $15.2M | $206M | $252M | $283M |
| Shareholders' equity | $14.1M | $7.2M | $293M | $92.2M | $21.8M |
| Net debt (β = net cash) | β$13.8M | β$3.3M | β$31.0M | β$13.7M | β$9.4M |
KIRA Β· Its return on capital was β619.7%: every 100 invested in the business earned about β620 in a year.
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
In plain words: How much profit the business makes on the money put into it. A higher percentage means each dollar invested works harder.
Return on capital, equity and assets (annual)
KIRA Β· Cibus, Inc. passes 3 of 8 financial health tests (Piotroski F-score).
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
In plain words: Nine yes/no tests of financial health, one point each. A green tick is a pass: 7 to 9 points is solid, 0 to 3 is weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | 4 / 8 | 3 / 8 | 2 / 8 | 2 / 8 | 4 / 9 | 3 / 9 | 2 / 8 | 3 / 8 | 3 / 8 |
| Accruals ratio | β17.1% | β29.7% | β8.1% | β7.4% | β1.5% | β20.7% | 8.3% | β78.1% | β43.2% | β23.4% |
| Altman Z'' | β5.54 | 4.08 | 4.90 | β0.78 | β8.40 | β20.02 | β36.33 | β5.15 | β11.44 | β11.34 |
Every number, year by year.
Amounts in USD. Hover a ratioβs name for its definition.
In plain words: Every number we have, year by year. Download it as a spreadsheet if you want to dig deeper.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $0.4M | $0.5M | $0.2M | $7.3M | $23.9M | $26.0M | $0.2M | $1.8M | $4.3M | $3.6M |
| Gross profit | $0.2M | $0.5M | $0.2M | β$2.0M | β$11.3M | β$2.6M | $0.2M | β | β | β |
| Research and development | $5.6M | $11.5M | $10.4M | $12.2M | $11.1M | $11.3M | $11.6M | $42.4M | $50.4M | $44.2M |
| Operating income | β$12.1M | β$25.8M | β$28.1M | β$39.7M | β$43.8M | β$29.3M | β$22.4M | β$319M | β$258M | β$97.5M |
| Interest expense | $0.0M | $0.3M | $1.3M | $1.5M | $1.4M | $1.4M | $0.1M | β | β | β |
| Pretax income | β$12.1M | β$26.0M | β$27.9M | β$39.6M | β$44.8M | β$29.2M | β$16.9M | β$338M | β$283M | β$132M |
| Income tax | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | β$0.0M | $0.0M | $0.0M |
| Net income | β$12.1M | β$26.0M | β$27.9M | β$39.6M | β$44.8M | β$29.2M | β$16.9M | β$268M | β$251M | β$127M |
| Diluted EPS | β$0.62 | β$1.12 | β$0.91 | β$1.21 | β$1.32 | β$0.78 | β$18.36 | β$25.95 | β$10.83 | β$2.78 |
| Diluted shares | 0.02B | 0.02B | 0.03B | 0.03B | 0.03B | 0.04B | 0.00B | 0.01B | 0.02B | 0.05B |
| Cash flow | ||||||||||
| Cash from operations | β$9.2M | β$12.8M | β$20.2M | β$32.0M | β$43.7M | β$18.8M | β$19.4M | β$46.2M | β$58.0M | β$50.6M |
| Capital expenditure | $10.4M | $0.8M | $1.8M | $3.0M | $1.8M | $0.5M | $1.5M | $4.3M | $0.8M | $0.6M |
| Free cash flow | β$19.7M | β$13.6M | β$22.0M | β$34.9M | β$45.5M | β$19.3M | β$20.9M | β$50.5M | β$58.9M | β$51.2M |
| Depreciation and amortization | $0.3M | $0.6M | $1.1M | $1.6M | $1.9M | $2.3M | $1.5M | $4.7M | $6.9M | $5.9M |
| Stock-based compensation | $0.9M | $12.1M | $4.4M | $9.2M | $5.0M | $2.1M | $4.0M | $16.1M | $10.8M | $8.2M |
| Share buybacks | β | β | $0.2M | $0.8M | β | β | β | β | β | β |
| Dividends and buybacks | β | β | $0.2M | $0.8M | β | β | β | β | β | β |
| Balance sheet | ||||||||||
| Cash and short-term investments | $5.0M | $56.7M | $93.8M | $58.6M | $29.0M | $13.8M | $3.4M | $32.7M | $14.4M | $9.9M |
| Total debt | β | β | β | β | $1.5M | $0.0M | $0.0M | $1.4M | $0.7M | $0.5M |
| Finance lease liabilities | β | $10.1M | $18.5M | $18.6M | β | β | $0.1M | $0.3M | $0.1M | β |
| Current assets | $5.5M | $57.5M | $95.5M | $63.5M | $39.6M | $15.2M | $4.1M | $35.2M | $16.9M | $12.1M |
| Current liabilities | $2.9M | $4.3M | $7.0M | $7.2M | $6.9M | $4.9M | $1.7M | $21.3M | $19.9M | $16.9M |
| Inventory | β | β | β | $2.6M | $1.4M | $0.0M | β | β | β | β |
| Property and equipment, net | $11.0M | $14.4M | $21.9M | $23.2M | $22.9M | $21.7M | $4.5M | β | β | β |
| Goodwill | β | β | β | β | β | β | $0.0M | $435M | $253M | $233M |
| Intangible assets | β | β | β | β | β | β | $0.2M | $35.4M | $33.6M | $31.7M |
| Total assets | $16.6M | $72.2M | $119M | $88.1M | $63.3M | $37.2M | $22.4M | $544M | $350M | $305M |
| Total liabilities | $3.5M | $14.7M | $25.4M | $25.6M | $26.5M | $23.1M | $15.2M | $206M | $252M | $283M |
| Shareholders' equity | $13.1M | $57.5M | $93.4M | $62.5M | $36.9M | $14.1M | $7.2M | $293M | $92.2M | $21.8M |
| Margins | ||||||||||
| Gross margin | 49.9% | 100.0% | 100.0% | β27.2% | β47.3% | β9.9% | 100.0% | β | β | β |
| Operating margin | β3,034.8% | β5,076.6% | β11,913.1% | β543.8% | β183.8% | β112.9% | β14,248.4% | β17,550.0% | β6,062.8% | β2,680.1% |
| EBITDA margin | β2,948.4% | β4,968.1% | β11,455.1% | β521.7% | β175.9% | β103.9% | β13,271.3% | β17,291.7% | β5,901.9% | β2,517.3% |
| Net margin | β3,029.1% | β5,114.2% | β11,820.8% | β542.9% | β188.0% | β112.4% | β10,758.6% | β14,729.1% | β5,898.4% | β3,492.3% |
| FCF margin | β4,927.6% | β2,670.1% | β9,342.8% | β478.6% | β190.6% | β74.3% | β13,301.9% | β2,781.0% | β1,380.8% | β1,406.1% |
| Returns | ||||||||||
| Return on capital | β | β | β | β | β368.5% | β7,499.1% | β464.3% | β96.1% | β260.4% | β619.7% |
| Return on capital employed | β88.0% | β38.0% | β25.2% | β49.0% | β77.7% | β90.7% | β107.8% | β61.0% | β78.3% | β33.8% |
| Return on equity | β92.1% | β73.6% | β37.0% | β50.8% | β90.2% | β114.5% | β158.1% | β178.0% | β130.4% | β223.0% |
| Return on assets | β72.7% | β58.5% | β29.2% | β38.3% | β59.2% | β58.1% | β56.7% | β94.4% | β56.2% | β38.8% |
| Return on tangible equity | β92.1% | β45.2% | β29.9% | β63.4% | β121.6% | β206.6% | β238.7% | β | β | β |
| Growth | ||||||||||
| Revenue growth | β | 27.3% | β53.5% | 2,991.5% | 226.9% | 9.0% | β99.4% | 1,057.3% | 134.6% | β14.6% |
| Share count change | β | 18.1% | 32.5% | 6.9% | 3.3% | 10.6% | β97.5% | 1,021.2% | 125.1% | 97.0% |
| Financial health | ||||||||||
| Debt / equity | β | β | β | β | 0.0x | 0.0x | 0.0x | 0.0x | 0.0x | 0.0x |
| Interest coverage | β2,421.8x | β98.8x | β22.4x | β26.6x | β30.5x | β20.5x | β298.3x | β | β | β |
| Current ratio | 1.9x | 13.5x | 13.6x | 8.8x | 5.7x | 3.1x | 2.5x | 1.7x | 0.9x | 0.7x |
| Quick ratio | 1.9x | 13.5x | 13.6x | 8.5x | 5.5x | 3.1x | 2.5x | 1.7x | 0.9x | 0.7x |
| Capital allocation | ||||||||||
| Capex / revenue | 2,612.5% | 153.3% | 782.6% | 40.7% | 7.5% | 1.9% | 968.2% | 237.8% | 19.0% | 15.9% |
| Stock comp / revenue | 237.6% | 2,380.3% | 1,858.1% | 125.8% | 20.8% | 8.0% | 2,546.5% | 885.6% | 252.2% | 225.0% |
| Quality scores | ||||||||||
| Piotroski F-score | β | 4.0 | 3.0 | 2.0 | 2.0 | 4.0 | 3.0 | 2.0 | 3.0 | 3.0 |
| Altman Z'' | β5.5 | 4.1 | 4.9 | β0.8 | β8.4 | β20.0 | β36.3 | β5.1 | β11.4 | β11.3 |
| Accruals ratio | β17.1% | β29.7% | β8.1% | β7.4% | β1.5% | β20.7% | 8.3% | β78.1% | β43.2% | β23.4% |
Source: SEC EDGAR XBRL filings (CIK 0001705843). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.
